{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T18:51:05Z","timestamp":1787079065333,"version":"build-2736575974"},"reference-count":45,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,3,27]],"date-time":"2015-03-27T00:00:00Z","timestamp":1427414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"French Ministry of Health (Programme Hospitalier de Recherche Clinique [PHRC] 2004)","award":["AOM 04008"],"award-info":[{"award-number":["AOM 04008"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatology"],"published-print":{"date-parts":[[2015,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate a new therapeutic strategy, with rapid corticosteroid dose tapering and limited cyclophosphamide (CYC) exposure, for older patients with systemic necrotizing vasculitides (SNVs; polyarteritis nodosa [PAN], granulomatosis with polyangiitis [Wegnener's] [GPA], microscopic polyangiitis [MPA], or eosinophilic GPA [Churg\u2010Strauss] [EGPA]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A multicenter, open\u2010label, randomized controlled trial comprising patients \u226565 years old and newly diagnosed as having SNV was conducted. The experimental treatment consisted of corticosteroids for \u223c9 months and a maximum of six 500\u2010mg fixed\u2010dose intravenous (IV) CYC pulses, every 2\u20133 weeks, then maintenance azathioprine or methotrexate. The control treatment included \u223c26 months of corticosteroids for all patients, combined with 500 mg\/m\n                      <jats:sup>2<\/jats:sup>\n                      IV CYC pulses, every 2\u20133 weeks until remission, then maintenance for all patients with GPA or MPA and for those with EGPA or PAN with a Five\u2010Factors Score (FFS) of \u22651. Randomization used a 1:1 ratio computer\u2010generated list and was performed centrally with sealed opaque envelopes. The primary outcome measure was \u22651 serious adverse event (SAE) occurring within 3 years of followup. Secondary outcome measures included remission and relapse rates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 108 patients randomized, 4 were excluded (early consent withdrawal or protocol violation). Mean \u00b1 SD age at diagnosis was 75.2 \u00b1 6.3 years. Analysis at 3 years included 53 patients (21 GPA, 21 MPA, 8 EGPA, and 3 PAN) in the experimental arm and 51 patients (15 GPA, 23 MPA, 6 EGPA, and 7 PAN) in the conventional arm. In total, 32 (60%) versus 40 (78%) had \u22651 SAE (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.04), most frequently infections; 6 (11%) versus 7 (14%) failed to achieve remission (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.71); 9 (17%) versus 12 (24%) died (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.41); and 20 (44%) of 45 versus 12 (29%) of 41 survivors in remission experienced a relapse (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.15).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>For older SNV patients, an induction regimen limiting corticosteroid exposure and with fixed low\u2010dose IV CYC pulses reduces SAEs in comparison to conventional therapy, and does not affect the remission rate. Three\u2010year relapse rates remain high for both arms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/art.39011","type":"journal-article","created":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T10:12:52Z","timestamp":1424254372000},"page":"1117-1127","source":"Crossref","is-referenced-by-count":172,"title":["Treatment of Systemic Necrotizing Vasculitides in Patients Aged Sixty\u2010Five Years or Older: Results of a Multicenter, Open\u2010Label, Randomized Controlled Trial of Corticosteroid and Cyclophosphamide\u2013Based Induction Therapy"],"prefix":"10.1002","volume":"67","author":[{"given":"Christian","family":"Pagnoux","sequence":"first","affiliation":[{"name":"National Referral Center for Necrotizing Vasculitides and Systemic Sclerosis, H\u00f4pital Cochin, AP\u2010HP, and Universit\u00e9 Paris Descartes Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Qu\u00e9m\u00e9neur","sequence":"additional","affiliation":[{"name":"Centre Hospitalier de Valenciennes Valenciennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Ninet","sequence":"additional","affiliation":[{"name":"H\u00f4pital Edouard Herriot Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Diot","sequence":"additional","affiliation":[{"name":"H\u00f4pital Bretonneau, Centre Hospitalier R\u00e9gional Universitaire de Tours Tours France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Kyndt","sequence":"additional","affiliation":[{"name":"Centre Hospitalier de Valenciennes Valenciennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"de Wazi\u00e8res","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire Car\u00e9meau N\u00eemes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean\u2010Luc","family":"Reny","sequence":"additional","affiliation":[{"name":"Centre Hospitalier B\u00e9ziers France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Pu\u00e9chal","sequence":"additional","affiliation":[{"name":"National Referral Center for Necrotizing Vasculitides and Systemic Sclerosis, H\u00f4pital Cochin, AP\u2010HP, and Universit\u00e9 Paris Descartes Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre\u2010Yves","family":"le Berruyer","sequence":"additional","affiliation":[{"name":"H\u00f4pital Robert Debr\u00e9, Centre Hospitalier Universitaire Reims France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lidove","sequence":"additional","affiliation":[{"name":"H\u00f4pital Bichat\u2013Claude Bernard Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Vanhille","sequence":"additional","affiliation":[{"name":"Centre Hospitalier de Valenciennes Valenciennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Godmer","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Bretagne Atlantique Vannes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Fain","sequence":"additional","affiliation":[{"name":"H\u00f4pital Jean Verdier Bondy France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Blockmans","sequence":"additional","affiliation":[{"name":"University Hospital Gasthuisberg Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Bienvenu","sequence":"additional","affiliation":[{"name":"National Referral Center for Necrotizing Vasculitides and Systemic Sclerosis, H\u00f4pital Cochin, AP\u2010HP, and Universit\u00e9 Paris Descartes Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Rollot","sequence":"additional","affiliation":[{"name":"National Referral Center for Necrotizing Vasculitides and Systemic Sclerosis, H\u00f4pital Cochin, AP\u2010HP, and Universit\u00e9 Paris Descartes Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"A\u00eft el Ghaz\u2010Poignant","sequence":"additional","affiliation":[{"name":"H\u00f4pital Cochin, AP\u2010HP Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Mahr","sequence":"additional","affiliation":[{"name":"National Referral Center for Necrotizing Vasculitides and Systemic Sclerosis, H\u00f4pital Cochin, AP\u2010HP, and Universit\u00e9 Paris Descartes Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Cohen","sequence":"additional","affiliation":[{"name":"National Referral Center for Necrotizing Vasculitides and Systemic Sclerosis, H\u00f4pital Cochin, AP\u2010HP, and Universit\u00e9 Paris Descartes Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[{"name":"National Referral Center for Necrotizing Vasculitides and Systemic Sclerosis, H\u00f4pital Cochin, AP\u2010HP, and Universit\u00e9 Paris Descartes Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Perrodeau","sequence":"additional","affiliation":[{"name":"H\u00f4pital H\u00f4tel\u2010Dieu and Universit\u00e9 Paris Descartes, INSERM U738 Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Ravaud","sequence":"additional","affiliation":[{"name":"H\u00f4pital H\u00f4tel\u2010Dieu and Universit\u00e9 Paris Descartes, INSERM U738 Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Guillevin","sequence":"additional","affiliation":[{"name":"National Referral Center for Necrotizing Vasculitides and Systemic Sclerosis, H\u00f4pital Cochin, AP\u2010HP, and Universit\u00e9 Paris Descartes Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the French Vasculitis Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,3,27]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200201000-00002"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.72.843.41"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e31816b2fbd"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.72.849.423"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2011.30"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1159\/000052838"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.088096"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-10-200905190-00004"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem146a"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330806"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330805"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330807"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370206"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199601000-00003"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020286"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.25061"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23822"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2004.11.005"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780091106"},{"key":"e_1_2_7_22_1","first-page":"671","article-title":"Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis","volume":"87","author":"Luqmani RA","year":"1994","journal-title":"Q J Med"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.062711"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0305-7372(93)90060-5"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2013.02.234"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.137778"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000180793.80212.17"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.489"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23198"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27340"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.03.003"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21142"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802311"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909905"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041884"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-14-73"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2013.02.299"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200311203492116"},{"key":"e_1_2_7_39_1","first-page":"2073","article-title":"The authors reply","volume":"349","author":"Jayne D","year":"2003","journal-title":"N Engl J Med"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(03)00077-9"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.34547"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200477"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1404231"},{"key":"e_1_2_7_44_1","first-page":"S313","article-title":"Safety of remission induction with rituximab versus cyclosphosphamide in patients 65 and older with severe ANCA\u2010associated vasculitis","volume":"65","author":"Miloslavsky E","year":"2013","journal-title":"Arthritis Rheum"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1213277"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.10.001"}],"container-title":["Arthritis &amp; Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.39011","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.39011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T12:57:10Z","timestamp":1759928230000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/art.39011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,27]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["10.1002\/art.39011"],"URL":"https:\/\/doi.org\/10.1002\/art.39011","archive":["Portico"],"relation":{},"ISSN":["2326-5191","2326-5205"],"issn-type":[{"value":"2326-5191","type":"print"},{"value":"2326-5205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,27]]}}}